Role of innate cytokines in mycobacterial infection

被引:218
作者
Cooper, A. M. [1 ]
Mayer-Barber, K. D. [2 ]
Sher, A. [2 ]
机构
[1] Trudeau Inst Inc, POB 59, Saranac Lake, NY 12983 USA
[2] NIAID, Parasit Dis Lab, Immunobiol Sect, NIH, Bethesda, MD 20892 USA
关键词
TUMOR-NECROSIS-FACTOR; BACILLUS-CALMETTE-GUERIN; TUBERCULOSIS INFECTION; IMMUNE-RESPONSE; HOST-DEFENSE; IFN-GAMMA; PULMONARY TUBERCULOSIS; LYMPHOTOXIN-ALPHA; T-CELLS; LISTERIA-MONOCYTOGENES;
D O I
10.1038/mi.2011.13
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cells of the innate immune system produce cytokines and lipid mediators that strongly influence the outcome of mycobacterial infection. In the case of Mycobacterium tuberculosis, the lung is a critical site for this interaction. Here, we review current information on the role of the major innate cytokine pathways both in controlling initial infection as well as in promoting and maintaining adaptive T-cell responses that mediate host resistance or immunopathology. Understanding this important feature of the host-pathogen interaction can provide major insights into the mechanisms of virulence and can lead to new approaches for immunological intervention in tuberculosis and other mycobacterial diseases.
引用
收藏
页码:252 / 260
页数:9
相关论文
共 102 条
[1]  
Alexandroff AB, 2010, IMMUNOTHERAPY-UK, V2, P551, DOI [10.2217/imt.10.32, 10.2217/IMT.10.32]
[2]   Limited Role for Lymphotoxin α in the Host Immune Response to Mycobacterium tuberculosis [J].
Allie, Nasiema ;
Keeton, Roanne ;
Court, Nathalie ;
Abel, Brian ;
Fick, Lizette ;
Vasseur, Virginie ;
Vacher, Rachel ;
Olleros, Maria L. ;
Drutskaya, Marina S. ;
Guler, Reto ;
Nedospasov, Sergei A. ;
Garcia, Irene ;
Ryffel, Bernhard ;
Quesniaux, Valerie F. J. ;
Jacobs, Muazzam .
JOURNAL OF IMMUNOLOGY, 2010, 185 (07) :4292-4301
[3]   Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency [J].
Altare, F ;
Durandy, A ;
Lammas, D ;
Emile, JF ;
Lamhamedi, S ;
Le Deist, F ;
Drysdale, P ;
Jouanguy, E ;
Döffinger, R ;
Bernaudin, F ;
Jeppsson, O ;
Gollob, JA ;
Meinl, E ;
Segal, AW ;
Fischer, A ;
Kumararatne, D ;
Casanova, JL .
SCIENCE, 1998, 280 (5368) :1432-1435
[4]   Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population [J].
Antonelli, Lis R. V. ;
Rothfuchs, Antonio Gigliotti ;
Goncalves, Ricardo ;
Roffe, Ester ;
Cheever, Allen W. ;
Bafica, Andre ;
Salazar, Andres M. ;
Feng, Carl G. ;
Sher, Alan .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (05) :1674-1682
[5]  
APPELBERG R, 1994, IMMUNOLOGY, V82, P361
[6]   Polymorphism in IL1B-ILIB-511 association with tuberculosis and decreased lipopolysaccharide-induced IL-1β in IFN-γ primed ex-vivo whole blood assay [J].
Awomoyi, AA ;
Charurat, M ;
Marchant, A ;
Miller, EN ;
Blackwell, JM ;
McAdam, KPWJ ;
Newport, MJ .
JOURNAL OF ENDOTOXIN RESEARCH, 2005, 11 (05) :281-286
[7]   Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis [J].
Awomoyi, AA ;
Marchant, A ;
Howson, JMM ;
McAdam, KPWJ ;
Blackwell, JM ;
Newport, MJ .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (12) :1808-1814
[8]   TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis [J].
Bafica, A ;
Scanga, CA ;
Feng, CG ;
Leifer, C ;
Cheever, A ;
Sher, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (12) :1715-1724
[9]   Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production [J].
Bafica, A ;
Scanga, CA ;
Serhan, C ;
Machado, F ;
White, S ;
Sher, A ;
Aliberti, J .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (06) :1601-1606
[10]   CYTOKINE PRODUCTION AT THE SITE OF DISEASE IN HUMAN TUBERCULOSIS [J].
BARNES, PF ;
LU, SZ ;
ABRAMS, JS ;
WANG, E ;
YAMAMURA, M ;
MODLIN, RL .
INFECTION AND IMMUNITY, 1993, 61 (08) :3482-3489